Ross Stores, Vertex Pharmaceuticals And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Lisa Levin
Insiders at Moderna, DXC Technology, Vertex Pharmaceuticals, and Ross Stores have recently sold significant amounts of shares. The reasons for these sales are not clear, but they could be due to preplanned sales or concerns about the companies' prospects. Moderna and a Chinese biotech are collaborating on a cancer vaccine, DXC Technology reported disappointing Q1 results, Vertex Pharmaceuticals' Q2 sales increased 14%, and Ross Stores reported better-than-expected Q2 results.
August 28, 2023 | 12:17 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Moderna's director sold 15,000 shares. The company is collaborating with a Chinese biotech on a cancer vaccine.
The sale of shares by an insider could indicate a lack of confidence in the company's prospects, but the collaboration on a cancer vaccine could also be a positive sign.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Ross Stores' President sold 25,945 shares. The company reported better-than-expected Q2 results.
The sale of shares by an insider could indicate a lack of confidence in the company's prospects, but the better-than-expected Q2 results could also be a positive sign.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Vertex Pharmaceuticals' EVP sold 2,500 shares. The company's Q2 sales increased 14%.
The sale of shares by an insider could indicate a lack of confidence in the company's prospects, but the increase in Q2 sales could also be a positive sign.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
DXC Technology's EVP & General Counsel sold 75,000 shares. The company reported disappointing Q1 results.
The sale of shares by an insider, combined with disappointing Q1 results, could indicate a lack of confidence in the company's prospects.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100